Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase NA 7Phase 2 4Phase 4 3Phase 2/3 2Phase 1 2

Status

Completed 47Recruiting 15Active not recruiting 13Terminated 9Unknown 4Withdrawn 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 2

Conditions

Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Daunorubicin × Clear all
NCT02660762 2017-06-19

Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL

Sun Yat-sen University

Phase 2 Unknown
100 enrolled
Other hematologic neoplasm

Leukemia

NCT00195871 2013-11-07

Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma

Centre Henri Becquerel

Phase 2 Unknown
155 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002531 2013-09-17

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
Other hematologic neoplasm

Leukemia

NCT00002532 2013-08-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡